Biopharmaceutical Company Selected By BARDA For Novel ARDS Treatment
InflaRx's GOHIBIC (Vilobelimab) Included in BARDA-Sponsored Clinical Trial for Acute Respiratory Distress Syndrome (ARDS).
Disclaimer: The following article is for informational purposes only. It does not aim to provide medical advice or endorse any specific therapeutic approaches. Always consult with a healthcare professional for medical guidance.
Real-time information is available daily at https://stockregion.net